Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks (Coresponding Author), COVID-19 Global Rheumatology Alliance, Jūlija Zepa (Member of the Working Group), Inita Buliņa (Member of the Working Group)

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)
1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds